The Biggest Diet Trend of 2020 Is Not a Diet
Since its inception, the practice of intermittent fasting has been linked to such benefits as increased lifespan, mitigation of chronic disease risk, and improvements in physical performance.
Since its inception, the practice of intermittent fasting has been linked to such benefits as increased lifespan, mitigation of chronic disease risk, and improvements in physical performance.
Researchers found several discrepancies in perception of disease outcomes between patients with acromegaly and their providers.
The high prevalence of overweight and obesity in youth with T1D was consistent across a multinational cohort and persistent over time.
Transgender youth on gender-affirming hormone therapy have differences in their percent fat and lean mass compared with cisgender youth.
The Food and Drug Administration (FDA) has approved Baqsimi (glucagon; Eli Lilly) nasal powder for the treatment of severe hypoglycemia in patients with diabetes aged 4 years and older.
Results showed non-inferiority for linagliptin vs glimepiride in meeting its primary endpoint of time to first occurrence of CV death, non-fatal myocardial infarction or non-fatal stroke.
The FDA has accepted for review the New Drug Application for an investigational triple combination tablet for the treatment of adults with type 2 diabetes.
Roux-en-Y gastric bypass is associated with a higher risk for nonvertebral fractures compared with adjustable gastric banding.
More marked increases in incidence observed from 2006 to 2013 than from 1973 to 2006
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.